The role of proton pump inhibitor therapy in the management of eosinophilic esophagitis

References

• Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3–20.
   PubMed Web of Science ®Google Scholar
• Attwood SE, Smyrk TC, Demeester TR, et al. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109–116.
   PubMed Web of Science ®Google Scholar
• Straumann A, Spichtin HP, Bernoulli R, et al. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings [in German with English abstract]. Schweiz Med Wochenschr. 1994;24:1419–1429.
   Google Scholar
• Arias Á, Pérez-Martínez I, Tenías JM, et al. Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2016;43:3–15.
   PubMed Web of Science ®Google Scholar
• Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363.
   PubMed Web of Science ®Google Scholar
• Molina-Infante J, Ferrando-Lamana A, Ripoll C, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2011;9:110–117.
   PubMed Web of Science ®Google Scholar
• Sayej WN, Patel R, Baker RD, et al. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2009;49:1–7.
   PubMed Web of Science ®Google Scholar
• Dranove JE, Horn DS, Davis MA, et al. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J Pediatr. 2009;154:96–100.
   PubMed Web of Science ®Google Scholar
• Peterson KA, Thomas KL, Hilden K, et al. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci. 2010;55:1313–1319.
   PubMed Web of Science ®Google Scholar
• Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679–692.
   PubMed Web of Science ®Google Scholar
• Papadopoulou A, Koletzko S, Heuschkel R, et al. Management guidelines of eosinophilic esophagitis in childhood. J Pediatr Gastroenterol Nutr. 2014;58:107–118.
   PubMed Web of Science ®Google Scholar
• Francis DL, Foxx-Orenstein A, Arora AS, et al. Results of ambulatory pH monitoring do not reliably predict response to therapy in patients with eosinophilic oesophagitis. Aliment Pharmacol Ther. 2012;35:300–307.
   PubMed Web of Science ®Google Scholar
• Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol. 2013;108:1854–1860.
   PubMed Web of Science ®Google Scholar
• Moawad FJ, Veerappan GR, Dias JA, et al. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia. Am J Gastroenterol. 2013;108:366–372.
   PubMed Web of Science ®Google Scholar
• Vazquez-Elizondo G, Ngamruengphong S, Khrisna M, et al. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther. 2013;38:1312–1319.
   PubMed Web of Science ®Google Scholar
• Molina-Infante J, Rivas MD, Hernandez-Alonso M, et al. Remission in proton pump inhibitor-responsive esophageal eosinophilia correlates with down regulation of eotaxin-3 and TH2 cytokines, similarly to eosinophilic esophagitis after steroids. Aliment Pharmacol Ther. 2014;40:955–965.
   PubMed Web of Science ®Google Scholar
• van Rhijn BD, Weijenborg PW, Verheij J, et al. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12:1815–1823.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Junquera C, Fernández-Fernández S, Cilleruelo ML, et al. High prevelance of response to proton pump inhibitor treatment in children with esophageal eosinophilia. J Pediatr Gastroenterol Nutr. 2015;1. doi:10.1097/MPG.0000000000001019.
   Web of Science ®Google Scholar
• Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histological remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14:13–22.e1.
   PubMed Web of Science ®Google Scholar
• Moawad FJ, Schoepfer AM, Safroneeva E, et al. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings. Aliment Pharmacol Ther. 2014;39:603–608.
   PubMed Web of Science ®Google Scholar
• Iwakura N, Fujiwara Y, Tanaka F, et al. Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia. Aliment Pharmacol Ther. 2015;41:776–784.
   PubMed Web of Science ®Google Scholar
• Warners MJ, van Rhijn BD, Curvers WL, et al. PPI-responsive esophageal eosinophilia cannot be distinguished from eosinophilic esophagitis by endoscopic signs. Eur J Gastroenterol Hepatol. 2015;27:506–511.
   PubMed Web of Science ®Google Scholar
• Moawad FJ, Wells JM, Johnson RL, et al. Comparison of eotaxin-3 biomarker in patients with eosinophilic oesophagitis, proton pump inhibitor-responsive oesophageal eosinophilia and gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2015;42:231–238.
   PubMed Web of Science ®Google Scholar
• Dellon ES, Speck O, Woodward K, et al. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study. Clin Gastroenterol Hepatol. 2014;12:2015–2022.
   PubMed Web of Science ®Google Scholar
• Wen T, Dellon ES, Moawad FJ, et al. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol. 2015;135:187–197.
   PubMed Web of Science ®Google Scholar
• Wen T, Stucke EM, Grotjan TM, et al. Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. Gastroenterology. 2013;145:1289–1299.
   PubMed Web of Science ®Google Scholar
• Rothenberg ME, Spergel JM, Sherrill JD, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet. 2010;42:289–291.
   PubMed Web of Science ®Google Scholar
• Kottyan LC, Davis BP, Sherrill JD, et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014;46:895–900.
   PubMed Web of Science ®Google Scholar
• Sleiman PMA, Wang ML, Cianferoni A, et al. GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun. 2014;5:5593.
   PubMed Web of Science ®Google Scholar
• Molina-Infante J, Bredenoord AJ, Cheng E, et al. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut. 2015; pii: gutjnl-2015-310991. doi:10.1136/gutjnl-2015-310991. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Molina-Infante J, Rodriguez-Sanchez J, Martinek J, et al. Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis. Am J Gastroenterol. 2015;110:1567–1575.
   PubMed Web of Science ®Google Scholar
• Gómez-Torrijos E, García-Rodríguez R, Castro-Jiménez A, et al. Efficacy of a step-down therapy in adult patients with proton pump inhibitor-responsive esophageal eosinophilia. Aliment Pharmacol Ther. 2016;43:534–540.
   PubMed Web of Science ®Google Scholar
• Molina-Infante J, van Rhijn BD. Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis. Best Pract Res Clin Gastroenterol. 2015;29:749–758.
   PubMed Web of Science ®Google Scholar
• Molina Infante J, Katzka DA, Gisbert JP. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis. Aliment Pharmacol Ther. 2013;37:1157–1164.
   PubMed Web of Science ®Google Scholar
• Tobey NA, Hosseini SS, Argote CM, et al. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol. 2004;99:13–22.
   PubMed Web of Science ®Google Scholar
• van Rhijn BD, Kessing BF, Smout AJ, et al. Oesophageal baseline impedance values are decreased in patients with eosinophilic oesophagitis. United European Gastroenterol J. 2013;1:242–248.
   PubMed Web of Science ®Google Scholar
• Straumann A, Schoepfer A. Update on basic and clinical aspects of eosinophilic oesophagitis. Gut. 2014;63:1355–1363.
   PubMed Web of Science ®Google Scholar
• Kia L, Hirano I. Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies. Nat Rev Gastroenterol Hepatol. 2015;12:379–386.
   PubMed Web of Science ®Google Scholar
• Rothenberg ME. Molecular, genetic, and cellular bases for treating eosinophilic esophagitis. Gastroenterology. 2015;148:1143–1157.
   PubMed Web of Science ®Google Scholar
• Cheng E, Zhang X, Huo X, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62:824–832.
   PubMed Web of Science ®Google Scholar
• Zhang X, Cheng E, Huo X, et al. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS One. 2012;7:e50037.
   PubMed Web of Science ®Google Scholar
• Krarup AL, Villadsen GE, Mejlgaard E, et al. Acid hypersensitivity in patients with eosinophilic oesophagitis. Scand J Gastroenterol. 2010;45:273–281.
   PubMed Web of Science ®Google Scholar
• Reimer C. Safety of long-term PPI therapy. Best Pract Res Clin Gastroenterol. 2013;27:443–454.
   PubMed Web of Science ®Google Scholar
• Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014;147:1238–1254.
   PubMed Web of Science ®Google Scholar
• Untersmayr E, Jensen-Jarolim E. The role of protein digestibility and antacids on food allergy outcomes. J Allergy Clin Immunol. 2008;121:1301–1308.
   PubMed Web of Science ®Google Scholar
• Untersmayr E, Schöll I, Swoboda I, et al. Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice. J Allergy Clin Immunol. 2003;112:616–623.
   PubMed Web of Science ®Google Scholar
• Diesner SC, Knittelfelder R, Krishnamurthy D, et al. Dose-dependent food allergy induction against ovalbumin under acid-suppression: a murine food allergy model. Immunol Lett. 2008;121:45–51.
   PubMed Web of Science ®Google Scholar
• Riemer AB, Gruber S, Pali-Schöll I, et al. Suppression of gastric acid increases the risk of developing immunoglobulin E-mediated drug hypersensitivity: human diclofenac sensitization and a murine sensitization model. Clin Exp Allergy. 2010;40:486–493.
   PubMed Web of Science ®Google Scholar
• Shakeri-Leidenmühler S, Lukschal A, Schultz C, et al. Surgical elimination of the gastric digestion by roux-en-y gastric bypass impacts on food sensitisation-a pilot study. Obes Surg. 2015;25:2268–2275.
   PubMed Web of Science ®Google Scholar
• Sodikoff J, Hirano I. Proton pump inhibitor-responsive esophageal eosinophilia does not preclude food-responsive eosinophilic esophagitis. J Allergy Clin Immunol. 2016;137:631–633.
   PubMed Web of Science ®Google Scholar
• Lucendo AJ, Arias A, Gonzalez-Cervera J, et al. Dual response to dietary/topical steroid and PPI therapy in adult patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2016;137:931–934.
   PubMed Web of Science ®Google Scholar